Literature DB >> 30666599

High-Throughput, Fast, and Sensitive Immunopeptidomics Sample Processing for Mass Spectrometry.

Fabio Marino1,2, Chloe Chong1,2, Justine Michaux1,2, Michal Bassani-Sternberg3,4.   

Abstract

Comprehensive knowledge of the HLA class I and class II peptides presented to T cells is crucial for designing innovative therapeutics against cancer and other diseases. So far, methodologies for recovery of HLA class I and II peptides for subsequent mass spectrometry-based analysis have been a major limitation. In this chapter we describe a detailed protocol for a high-throughput, reproducible, and sensitive immunoaffinity-purification of HLA-I and HLA-II peptides from up to 96 samples in a plate format, suitable for tissue samples and cell lines. Our methodology reduces sample handling, has a competitive peptide yield, and can be completed within 5 h. This simplified pipeline is applicable for basic and clinical applications.

Entities:  

Keywords:  Affinity purification; Antigen processing and presentation; HLA class I and HLA class II; Human leukocyte antigen; Immunopeptidomics; Mass spectrometry

Mesh:

Substances:

Year:  2019        PMID: 30666599     DOI: 10.1007/978-1-4939-8979-9_5

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  13 in total

1.  The role of proteomics in assessing beta-cell dysfunction and death in type 1 diabetes.

Authors:  Ernesto S Nakayasu; Wei-Jun Qian; Carmella Evans-Molina; Raghavendra G Mirmira; Decio L Eizirik; Thomas O Metz
Journal:  Expert Rev Proteomics       Date:  2019-06-24       Impact factor: 3.940

2.  The Human Immunopeptidome Project: A Roadmap to Predict and Treat Immune Diseases.

Authors:  Juan Antonio Vizcaíno; Peter Kubiniok; Kevin A Kovalchik; Qing Ma; Jérôme D Duquette; Ian Mongrain; Eric W Deutsch; Bjoern Peters; Alessandro Sette; Isabelle Sirois; Etienne Caron
Journal:  Mol Cell Proteomics       Date:  2019-11-19       Impact factor: 5.911

3.  A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancreatic Adenocarcinoma-A Proof of Antigen Discovery Feasibility in Three Patients.

Authors:  Michal Bassani-Sternberg; Antonia Digklia; Florian Huber; Dorothea Wagner; Christine Sempoux; Brian J Stevenson; Anne-Christine Thierry; Justine Michaux; HuiSong Pak; Julien Racle; Caroline Boudousquie; Klara Balint; George Coukos; David Gfeller; Silvia Martin Lluesma; Alexandre Harari; Nicolas Demartines; Lana E Kandalaft
Journal:  Front Immunol       Date:  2019-08-08       Impact factor: 7.561

4.  A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade ovarian serous carcinoma.

Authors:  Apostolos Sarivalasis; Caroline Boudousquié; Klara Balint; Brian J Stevenson; Philippe O Gannon; Emanuela Marina Iancu; Laetitia Rossier; Silvia Martin Lluesma; Patrice Mathevet; Christine Sempoux; George Coukos; Urania Dafni; Alexandre Harari; Michal Bassani-Sternberg; Lana E Kandalaft
Journal:  J Transl Med       Date:  2019-11-26       Impact factor: 5.531

Review 5.  Neoantigens in Hematological Malignancies-Ultimate Targets for Immunotherapy?

Authors:  Malte Roerden; Annika Nelde; Juliane S Walz
Journal:  Front Immunol       Date:  2019-12-20       Impact factor: 7.561

6.  Rapid tumor vaccine using Toll-like receptor-activated ovarian cancer ascites monocytes.

Authors:  Sarah F Adams; Alizée J Grimm; Cheryl L-L Chiang; Ananda Mookerjee; Dallas Flies; Stephanie Jean; Georgia A McCann; Justine Michaux; HuiSong Pak; Florian Huber; Christopher Neal; Denarda Dangaj; Michal Bassani-Sternberg; Sylvie Rusakiewicz; Andrea Facciabene; George Coukos; Phyllis A Gimotty; Lana E Kandalaft
Journal:  J Immunother Cancer       Date:  2020-08       Impact factor: 13.751

7.  Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomes.

Authors:  Chloe Chong; Markus Müller; HuiSong Pak; Dermot Harnett; Florian Huber; Delphine Grun; Marion Leleu; Aymeric Auger; Marion Arnaud; Brian J Stevenson; Justine Michaux; Ilija Bilic; Antje Hirsekorn; Lorenzo Calviello; Laia Simó-Riudalbas; Evarist Planet; Jan Lubiński; Marta Bryśkiewicz; Maciej Wiznerowicz; Ioannis Xenarios; Lin Zhang; Didier Trono; Alexandre Harari; Uwe Ohler; George Coukos; Michal Bassani-Sternberg
Journal:  Nat Commun       Date:  2020-03-10       Impact factor: 14.919

Review 8.  Machine Learning for Cancer Immunotherapies Based on Epitope Recognition by T Cell Receptors.

Authors:  Anja Mösch; Silke Raffegerst; Manon Weis; Dolores J Schendel; Dmitrij Frishman
Journal:  Front Genet       Date:  2019-11-19       Impact factor: 4.599

9.  Biogenesis of HLA Ligand Presentation in Immune Cells Upon Activation Reveals Changes in Peptide Length Preference.

Authors:  Fabio Marino; Aikaterini Semilietof; Justine Michaux; Hui-Song Pak; George Coukos; Markus Müller; Michal Bassani-Sternberg
Journal:  Front Immunol       Date:  2020-08-28       Impact factor: 7.561

10.  Solving an MHC allele-specific bias in the reported immunopeptidome.

Authors:  Martin G Klatt; Kyeara N Mack; Yang Bai; Zita E H Aretz; Levy I Nathan; Sung Soo Mun; Tao Dao; David A Scheinberg
Journal:  JCI Insight       Date:  2020-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.